Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Acknowledgement, ADA, aimed, Alfasigma, amplified, analyzed, antithrombotic, argued, armed, Asia, assay, BI, Boehringer, cardiogenic, cardiothoracic, CDE, CDPA, COBRA, Colorado, Commonwealth, copy, CPA, CPRA, culture, CytoSorbent, deferral, deny, died, dismissed, EEA, exacerbated, excellent, fulfill, hybrid, ID, identification, Ingelheim, Inline, instability, involuntary, Italy, lump, MAA, maker, MFN, MHRA, migration, multitude, network, outset, Page, penny, preceding, prespecified, pretreatment, purport, reevaluate, reprioritize, rescinded, resignation, Russia, salary, sensitive, septic, shape, shock, sum, terrorist, theft, thousand, thrombotic, topline, Ukraine, unchanged, unconditional, unconditionally, unrest, unsettled, vaccinated, vaccination, vaccine, vice, Virginia, withholding, workplace
Removed:
abdominal, abnormal, Acceleron, Actelion, activation, Adcirca, agonist, airway, ambisentan, Arena, ascending, Bardoxolone, baseline, Bayer, Bellerophon, Beraprost, Bio, blinded, blocking, bosentan, breath, bred, broaden, cardiomyopathy, catheterization, cell, CF, CFTR, chance, characterized, circulating, Citigroup, conform, connective, constriction, continuously, contractibility, contractility, contrast, corrected, crystal, curative, cystic, degraded, diagnosed, diastolic, dilate, dilation, disappear, discontinued, disposable, distance, distension, DMD, domain, drew, dry, Duchenne, dysfunction, Dystrophy, ejection, enabling, engine, enhanced, enhancing, epithelial, erythema, escalated, excluding, exhibited, exploratory, exploring, fainting, fatigue, gastrointestinal, gel, gene, Gilead, Gossamer, hemodynamic, HFrEF, highest, hypotension, iloprost, improved, inactive, incidence, Index, inflammation, inflammatory, informally, inhaler, injection, INOpulse, Insmed, IP, isomer, itching, judge, judged, Justin, Klein, lacking, lieu, Liquidia, lowering, lung, macitentan, MannKind, markedly, mechanism, median, methyl, mice, mild, mimic, minute, moderately, modulate, modulating, molecular, muscle, Muscular, mutation, nanoparticle, naturally, neurohormone, neutralizing, nitric, nonroyalty, Notably, observational, occurring, Opsumit, opted, orthostatic, output, oxide, oxygen, oxygenation, patch, PBC, Peter, Pfizer, phosphodiesterase, pilot, powder, predominantly, preferentially, premature, preserved, processing, prodrug, progressed, progressive, proliferation, prolonged, prostacyclin, purely, quantity, Ralinepag, rat, reaction, Reata, recruited, relax, relaxation, remodeling, Remodulin, repaid, Representative, reproduced, resistance, respiratory, responding, restriction, resumed, Revatio, reviewed, scarring, selexipag, serum, sildenafil, singular, skeletal, smooth, sodium, Sotatercept, stimulate, strategically, structural, suggest, surface, symptomatic, systemic, systolic, tadalafil, Technosphere, thereof, tissue, titled, Tracleer, tract, transmembrane, treprostinil, Trevyent, underfilling, Uptravi, vascular, vasoactive, vasoconstriction, vasoconstrictive, vasoconstrictor, vasodilation, vasodilator, vasodilatory, ventricle, view, walk, wall, widen, worsen, York
Filing tables
Filing exhibits
Related press release
PHASQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-227935, 333-230504, 333-237462, 333-254268, and 333-262185) on Form S-8 and in the registration statement (No. 333-235735) on Form S-3 of our report dated March 24, 2022, with respect to the financial statements of PhaseBio Pharmaceuticals, Inc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
March 24, 2022